Additional information
Indication | Kidney cancer |
---|---|
Strength | Pazopanib (400mg) |
Manufacturer | Glaxo SmithKline Pharmaceuticals Ltd |
Pharmaceutical Form | Tablet |
Pack Size | 30 Tablet, 60 Tablet, 90 Tablet, 120 Tablet, 180 Tablet |
$180.00 – $1,007.00
Votrient 400 mg (Pazopanib) Tablet is a protein kinase inhibitor to handle kidney cancer and soft tissue sarcoma.
Indication | Kidney cancer |
---|---|
Strength | Pazopanib (400mg) |
Manufacturer | Glaxo SmithKline Pharmaceuticals Ltd |
Pharmaceutical Form | Tablet |
Pack Size | 30 Tablet, 60 Tablet, 90 Tablet, 120 Tablet, 180 Tablet |
Reviews
There are no reviews yet.